Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.

This study has been completed.

Study NCT00268697 Information provided by Takeda Global Research & Development Center, Inc.

First Received: December 20, 2005 Last Updated: June 7, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2007
Primary Completion Date:	January 2007 (Final data collection date for primary outcome measure)

No publications provided by Takeda Global Research & Development Center, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Stein EA, Bays H, O'Brien D, Pedicano J, Piper E, Spezzi A. Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia. Circulation. 2011 May 10;123(18):1974-85. Epub 2011 Apr 25.